or Try an Advanced Search...

    Molecule Therapeutics Stocks List

    Symbol Grade Name % Change
    KZR C Kezar Life Sciences, Inc. -3.22
    ARDX D Ardelyx, Inc. 3.75
    MNOV D MediciNova, Inc. -1.19
    ENTX D Entera Bio Ltd. -0.55
    ZNTL D Zentalis Pharmaceuticals, Inc. 21.61
    CYTK F Cytokinetics, Incorporated 1.61
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Biotechnology Cancer Clinical Development Hormones Amyotrophic Lateral Sclerosis Antiestrogens Asthma Autoimmunity Breast Cancer Bronchial Asthma Central Nervous System Disorders Chronic Kidney Disease Constipation Cytokine Disease Drug Design Drugs Dysfunction End Stage Renal Disease

    Related ETFs - A few ETFs which own one or more of the above listed Molecule Therapeutics stocks.

    Symbol Grade Name Weight
    SURI A Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 3.39
    HRTS D Tema Cardiovascular and Metabolic ETF 3.25
    XBI B SPDR S&P Biotech ETF 2.24
    LABU C Direxion Daily S&P Biotech Bull 3X Shares 1.44
    BBP A BioShares Biotechnology Products Fund 1.34
    View all Molecule Therapeutics ETFs...
    Compare ETFs
    Compare HRTS to BBP Compare HRTS to LABU Compare XBI to BBP

        Molecule Therapeutics Stocks Recent News

        Date Stock Title
        Nov 1 ARDX Q3 2024 Ardelyx Inc Earnings Call
        Nov 1 ARDX Ardelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ...
        Nov 1 ARDX Ardelyx, Inc. (ARDX) Q3 2024 Earnings Call Transcript
        Oct 31 ARDX Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics
        Oct 31 ARDX Ardelyx (ARDX) Reports Break-Even Earnings for Q3
        Oct 31 ARDX Ardelyx Beats Q3 Sales Estimates, Shares Climb
        Oct 31 ARDX Ardelyx: Q3 Earnings Snapshot
        Oct 31 ARDX Ardelyx GAAP EPS of $0.00 beats by $0.05, revenue of $98.24M beats by $11.6M
        Oct 31 ARDX Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
        Oct 30 ARDX Ardelyx Q3 2024 Earnings Preview
        Oct 29 KZR Looking Into Kezar Life Sciences's Recent Short Interest
        Oct 28 ARDX Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
        Oct 28 ARDX Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
        Oct 28 KZR Kezar Life Sciences announces 1-for-10 reverse stock split
        Oct 28 KZR Kezar Life Sciences Announces 1-for-10 Reverse Stock Split
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Biotechnology Cancer Clinical Development Hormones Amyotrophic Lateral Sclerosis Antiestrogens Asthma Autoimmunity Breast Cancer Bronchial Asthma Central Nervous System Disorders Chronic Kidney Disease Constipation Cytokine Disease Drug Design Drugs Dysfunction End Stage Renal Disease
        Molecule Therapeutics

        Molecule Therapeutics is a branch of biotechnology that focuses on the development of therapeutic molecules for the treatment of diseases. This includes the development of small molecules, peptides, proteins, and nucleic acids for therapeutic use. Molecule Therapeutics also involves the study of the structure and function of molecules, as well as the development of new methods for drug delivery.

        Browse All Tags